634
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children

, , , , , , , , , , , , & show all
Pages 382-388 | Received 30 Jul 2012, Accepted 27 Oct 2012, Published online: 04 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shabir A Madhi, Anthonet Koen, Lisa Jose, Marta Moreira, Nadia van Niekerk, Clare Cutland, Nancy François, Javier Ruiz-Guiñazú, Juan Pablo Yarzabal, Dorota Borys & Lode Schuerman. (2017) Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial. Expert Review of Vaccines 16:6, pages 641-656.
Read now
A Odutola, MO Ota, EO Ogundare, M Antonio, P Owiafe, A Worwui, B Greenwood, M Alderson, M Traskine, V Verlant, K Dobbelaere & D Borys. (2016) Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study. Human Vaccines & Immunotherapeutics 12:2, pages 393-402.
Read now
Alassane Dicko, Yahia Dicko, Amadou Barry, Youssoufa Sidibe, Almahamoudou Mahamar, Gaoussou Santara, Amagana Dolo, Aminata Diallo, Ogobara Doumbo, Fakrudeen Shafi, Nancy François, Juan Pablo Yarzabal, Ana Strezova, Dorota Borys & Lode Schuerman. (2015) Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study. Human Vaccines & Immunotherapeutics 11:9, pages 2207-2214.
Read now

Articles from other publishers (8)

Els van Westen, Mirjam Knol, Alienke Wijmenga-Monsuur, Irina Tcherniaeva, Leo Schouls, Elisabeth Sanders, Cecile van Els, Guy Berbers & Nynke Rots. (2018) Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine. Vaccines 6:4, pages 82.
Crossref
Ava Behrouzi, Saeid Bouzari, Mana Oloomi, Abolfazl Fateh, Farzam Vaziri, Parviz Afrough, Seyed Davar Siadat & Atefeh Davoudi Vijeh Motlagh. (2018) Truncated D Protein as a New Vaccine Candidate Against Nontypeable Haemophilus influenza. Archives of Pediatric Infectious Diseases 6:2.
Crossref
Khalequ Zaman, Sheikh Farzana Zaman, Farzana Zaman, Asma Aziz, Sayeed-Bin Faisal, Magali Traskine, Md Ahsan Habib, Javier Ruiz-Guiñazú & Dorota Borys. (2018) Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study. Vaccine 36:5, pages 698-706.
Crossref
Sodiomon B. Sirima, Alfred Tiono, Zakaria Gansané, Mohamadou Siribié, Angèle Zongo, Alphonse Ouédraogo, Nancy François, Ana Strezova, Kurt Dobbelaere & Dorota Borys. (2017) Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age. Pediatric Infectious Disease Journal 36:5, pages e136-e150.
Crossref
Shabir A. Madhi, Anthonet Koen, Lisa Jose, Nadia van Niekerk, Peter V. Adrian, Clare Cutland, Nancy François, Javier Ruiz-Guiñazú, Juan-Pablo Yarzabal, Marta Moreira, Dorota Borys & Lode Schuerman. (2017) Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine 96:2, pages e5881.
Crossref
Chinh C. Ngo, Helen M. Massa, Ruth B. Thornton & Allan W. Cripps. (2016) Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review. PLOS ONE 11:3, pages e0150949.
Crossref
Greg L. Plosker. (2014) 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine: A Review in Infants and Children. Pediatric Drugs 16:5, pages 425-444.
Crossref
Laura L. Hammitt, John Ojal, Mahfudh Bashraheil, Susan C. Morpeth, Angela Karani, Ahsan Habib, Dorota Borys, David Goldblatt & J. Anthony G Scott. (2014) Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1–4 Years: A Randomized Controlled Trial. PLoS ONE 9:1, pages e85459.
Crossref